title: First-order logic theory for manipulating clinical practice guidelines applied to comorbid patients: a case study.
abstract: Clinical practice guidelines (CPGs) implement evidence-based medicine designed to help generate a therapy for a patient suffering from a single disease. When applied to a comorbid patient, the concurrent combination of treatment steps from multiple CPGs is susceptible to adverse interactions in the resulting combined therapy (i.e., a therapy established according to all considered CPGs). This inability to concurrently apply CPGs has been shown to be one of the key shortcomings of CPG uptake in a clinical setting1. Several research efforts are underway to address this issue such as the K4CARE2 and GuideLine INteraction Detection Assistant (GLINDA)3 projects and our previous research on applying constraint logic programming to developing a consistent combined therapy for a comorbid patient4. However, there is no generalized framework for mitigation that effectively captures general characteristics of the problem while handling nuances such as time and ordering requirements imposed by specific CPGs. In this paper we propose a first-order logic-based (FOL) approach for developing a generalized framework of mitigation. This approach uses a meta-algorithm and entailment properties to mitigate (i.e., identify and address) adverse interactions introduced by concurrently applied CPGs. We use an illustrative case study of a patient suffering from type 2 diabetes being treated for an onset of severe rheumatoid arthritis to show the expressiveness and robustness of our proposed FOL-based approach, and we discuss its appropriateness as the basis for the generalized theory.
authors.affiliation: Adventium Labs, Minneapolis, MN.
authors.forename: Martin
authors.initials: M
authors.lastname: Michalowski
authors.affiliation: Poznan University of Technology, Poznan, Poland.
authors.forename: Szymon
authors.initials: S
authors.lastname: Wilk
authors.affiliation: University of Ottawa, Ottawa, Canada.
authors.forename: Xing
authors.initials: X
authors.lastname: Tan
authors.affiliation: University of Ottawa, Ottawa, Canada.
authors.forename: Wojtek
authors.initials: W
authors.lastname: Michalowski
mesh_terms: D000368:Aged; D001172:Arthritis, Rheumatoid / Q000150:complications / Q000188:drug therapy*; D015897:Comorbidity; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000188:drug therapy*; D019317:Evidence-Based Medicine; D005938:Glucocorticoids / Q000008:administration & dosage*; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage*; D007328:Insulin / Q000008:administration & dosage*; D008297:Male; D008954:Models, Biological; D017410:Practice Guidelines as Topic
chemical_list: D005938:Glucocorticoids; D007004:Hypoglycemic Agents; D007328:Insulin